People talk as if AI will suddenly make drug discovery cheap and easy. Why is that view incomplete?
Replied byDave Ricks
Chair & CEO at Eli Lilly and Company
Niche: Pharmaceuticals, AI, Health & Wellness
Revenue: $1M+/month
Location: USA
Started: 2015 or
AI can find targets, propose molecules, and flag some toxicity earlier. It makes the front end faster. But you still have to test drugs in real people across many countries over long periods. Most cost and time sits in rigorous clinical trials, so AI improves odds but does not erase the need for careful testing.
0
From the Full Interview
This answer is part of a full interview with Dave Ricks, Chair & CEO at Eli Lilly and Company.
Share this Answer
Found this insight valuable? Share it with your network to help others learn from Dave Ricks's experience.
Cite This Answer
Use this answer in your research, article, or academic work
Related Answers
Did your childhood environment play a role in fostering your entrepreneurial drive?
By Allison Ellsworth
Retail
Approx. $42 Million/mo
How did your experience in the oil and gas industry help prepare you for entrepreneurship?
By Allison Ellsworth
Retail
Approx. $42 Million/mo
What inspired you to begin formulating a prebiotic beverage in your kitchen?
By Allison Ellsworth
Retail
Approx. $42 Million/mo
What led to the decision to increase the sugar content in your initial formulation?
By Allison Ellsworth
Retail
Approx. $42 Million/mo
Why is scale becoming more important for dealers?
By Dave Mondragon
Retail
/mo
Why is dealer ownership central to the business?
By Dave Mondragon
Retail
/mo
What is your long-term vision?
By Dave Mondragon
Retail
/mo